Clinicopathologic features and long-term follow-up of metastatic gastrointestinal stromal tumor (GIST) patients (pts) with durable response (≥ 5 years) to frontline imatinib (IM): A case-control study from GEIS
2019 ◽
Vol 19
(10)
◽
pp. e287-e288
Keyword(s):
2017 ◽
Vol 13
(4)
◽
pp. 575-580
◽
Keyword(s):
Keyword(s):
2018 ◽
Vol 93
(4)
◽
pp. 445-452
◽
2016 ◽
Vol 134
(6)
◽
pp. 434-441
◽
Keyword(s):
2011 ◽
Vol 91
(11)
◽
pp. 1265-1272
◽
Keyword(s):
2019 ◽
Vol 7
(8)
◽
pp. 1042-1050
Keyword(s):